Status:

COMPLETED

A Study of Comparing Safety and Reactogenicity, of Lyophilized BCG Vaccine IP of Green Signal Bio Pharma Private Limited, India With BCG Vaccine of Serum Institute of India Limited in 120 Healthy Children.

Lead Sponsor:

Green Signal Biopharma Private Limited

Conditions:

Healthy

Eligibility:

All Genders

Up to 14 years

Phase:

PHASE3

Brief Summary

To compare Safety and Reactogenecity of BCG vaccine of Green Signal Biopharma Private Limited India with BCG vaccine of serum institute of India limited (SIIL), India in 120 healthy children.

Detailed Description

The study was conducted in the objective to compare the safety and reactogenecity of BCG Vaccine of Green Signal Bio pharma Private Limited India(Test) with BCG vaccine of Serum Institute of India(Ref...

Eligibility Criteria

Inclusion

  • Subjects must be in the age group of 0 - 14 years of age.
  • Subject's parent should be able to understand and have to sign the informed consent form after being explained by the investigator. They must be aware of the experimental nature of the therapy, its potential benefits, side effects and risks.
  • Ability to comply with the schedule of treatment and follow-up.
  • Absence of BCG scar
  • Tuberculin negative
  • No evidence of any other infection
  • No evidence of skin disease -

Exclusion

  • History or presence of significant:
  • Cardiovascular, pulmonary, hepatic, renal, hematological, gastrointestinal, endocrinal, immunologic, dermatologic, neurological or psychiatric disease.
  • More specifically, history or presence of significant:
  • Low birth weight babies (\<2.5 Kg),
  • Malignancy,
  • Tuberculin positive,
  • Hodgkin's disease,
  • Corticosteroid therapy,
  • Generalised Eczema,
  • Infective dermatosis,
  • Hypogammaglobulinemia,
  • Immunosuppressed,
  • Above 14 years of age,
  • On anti-tubercular drugs,
  • Chest X ray evidence of TB.
  • \-

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2009

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT01250249

Start Date

November 1 2008

End Date

June 1 2009

Last Update

November 30 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Arya vysya maternity home & child welfare centre

Chennai, Tamil Nadu, India, 600001